Flow cytometric determination of 5-bromo-2ʹ-deoxyuridine pharmacokinetics in blood serum after intraperitoneal administration to rats and mice

Histochemistry and Cell Biology

Volumn 142, Issue 6, 2014, Pages 703-712

  Matiašová, Anna ^a   Ševc, Juraj ^a   Mikeš, Jaromír ^a   Jendželovský, Rastislav ^a   Daxnerová, Zuzana ^a   Fedoročko, Peter ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

5 Bromo 2 deoxyuridine; BrdU; Intraperitoneal administration; Mice; Pharmacokinetic; Rat

Indexed keywords

BROXURIDINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HCT116 CELL LINE; HL 60 CELL LINE; IN VITRO STUDY; LIMIT OF DETECTION; MALE; MOUSE; NONHUMAN; RAT; SINGLE DRUG DOSE; SPINAL CORD TRANSSECTION; STAINING; ANIMAL; BLOOD; DOSE RESPONSE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION;

MUS; RATTUS;

ANIMALS; BROMODEOXYURIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MICE; RATS;

EID: 84911986538     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-014-1253-7     Document Type: Article

References (24)

1. Barker JM, Charlier TD, Ball GF, Balthazart J (2013) A new method for in vitro detection of bromodeoxyuridine in serum: a proof of concept in a songbird species, the canary. PLoS One 8. doi:10.1371/journal.pone.0063692
2. Cameron HA, McKay RDG (2001) Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 435:406–417
3. Cooper-Kuhn CM, Kuhn HG (2002) Is it all DNA repair? methodological considerations for detecting neurogenesis in the adult brain. Dev Brain Res 134:13–21
4. Duque A, Rakic P (2011) Different effects of bromodeoxyuridine and [3h]thymidine incorporation into DNA on cell proliferation, position, and fate. J Neurosci 31:15205–15217. doi:10.1523/jneurosci.3092-11.2011
5. Eadie BD, Redila VA, Christie BR (2005) Voluntary exercise alters the cytoarchitecture of the adult dentate gyrus by increasing cellular proliferation, dendritic complexity, and spine density. J Comp Neurol 486:39–47
6. Hayes NL, Nowakowski RS (2000) Exploiting the dynamics of S-phase tracers in developing brain: interkinetic nuclear migration for cells entering versus leaving the S-phase. Dev Neurosci 22:44–55
7. Horner PJ et al (2000) Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20:2218–2228
8. Kolb B, Pedersen B, Ballermann M, Gibb R, Whishaw IQ (1999) Embryonic and postnatal injections of bromodeoxyuridine produce age-dependent morphological and behavioral abnormalities. J Neurosci 19:2337–2346
9. Kriss JP, Revesz L (1962) The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat. Cancer Res 22:254–265
10. Kriss JP, Maruyama Y, Tung LA, Bond SB, Revesz L (1963) The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidine in man. Cancer Res 23:260–268
11. Kuan HY, Smith DE, Ensminger WD, Knol JA, DeRemer SJ, Yang Z, Stetson PL (1996) Regional pharmacokinetics of 5-bromo-2′-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions. Cancer Res 56:4724–4727
12. Kuhn HG, Cooper-Kuhn CM (2007) Bromodeoxyuridine and the detection of neurogenesis. Curr Pharm Biotechnol 8:127–131. doi:10.2174/138920107780906531
13. Mandyam CD, Harburg GC, Eisch AJ (2007) Determination of key aspects of precursor cell proliferation, cell cycle length and kinetics in the adult mouse subgranular zone. Neuroscience 146:108–122. doi:10.1016/j.neuroscience.2006.12.064
14. Mikeš J, Ševc J, Košuth J, Matiašová A, Daxnerová Z, Fedoročko P (2014) Flow cytometric method for estimation of 5-bromo-2′-deoxyuridine content in rat serum. Phys Res (in press)
15. Nowakowski RS, Rakic P (1974) Clearance rate of exogenous 3H thymidine from the plasma of pregnant rhesus monkeys. Cell Tissue Kinet 7:189–194
16. Nowakowski RS, Lewin SB, Miller MW (1989) Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population. J Neurocytol 18:311–318
17. Packard DS Jr, Menzies RA, Skalko RG (1973) Incorporation of thymidine and its analogue, bromodeoxyuridine, into embryos and maternal tissues of the mouse. Differentiation 1:397–404
18. Phuphanich S, Levin VA (1985) Bioavailability of bromodeoxyuridine in dogs and toxicity in rats. Cancer Res 45:2387–2389
19. Rubini JR, Cronkite EP, Bond VP, Fliedner TM (1960) The metabolism and fate of tritiated thymidine in man. J Clin Invest 39:909–918
20. Russo A et al (1984) Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors. Cancer Res 44:1702–1705
21. Sekerková G, Ilijic E, Mugnaini E (2004) Bromodeoxyuridine administered during neurogenesis of the projection neurons causes cerebellar defects in rat. J Comp Neurol 470:221–239. doi:10.1002/cne.11016
22. Ševc J, Daxnerová Z, Haňová V, Koval J (2011) Novel observations on the origin of ependymal cells in the ventricular zone of the rat spinal cord. Acta Histochem 113:156–162. doi:10.1016/j.acthis.2009.09.007
23. Staroscik RN, Jenkins WH, Mendelsohn ML (1964) Availability of tritiated thymidine after intravenous administration. Nature 202:456–458
24. Taupin P (2007) BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res Rev 53:198–214. doi:10.1016/j.brainresrev.2006.08.002